サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1715190

アジア太平洋のリキッドバイオプシー用採血管市場：2031年までの予測 - 地域別分析 - 製品別、材料別、用途別、エンドユーザー別

Asia Pacific Blood Collection Tubes for Liquid Biopsy Market Forecast to 2031 - Regional Analysis - by Product, Material, Application, and End User

出版日
ページ情報
英文 123 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
アジア太平洋のリキッドバイオプシー用採血管市場：2031年までの予測 - 地域別分析 - 製品別、材料別、用途別、エンドユーザー別
出版日: 2025年02月11日
発行: The Insight Partners
ページ情報: 英文 123 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋のリキッドバイオプシー用採血管市場は、2023年に287億4,623万米ドルと評価され、2031年までには1,161億6,956万米ドルに達すると予測され、2023年から2031年までのCAGRは19.1%と推定されます。

がんモニタリングにおけるリキッドバイオプシーの利用がアジア太平洋のリキッドバイオプシー用採血管を押し上げる

がん増殖のモニタリング、遺伝子変異の検出、再発の兆候の特定、免疫療法に対する感受性の予測にリキッドバイオプシーを採用することに注目が集まっています。がんの早期発見はより良い転帰をもたらします。例えば、早期発見の患者は末期がんや悪性がんの患者よりも寛解率や生存率が高いです。しかし、症状が明らかでない初期の段階でがんを発見するために、がんサーベイランスのために連続的な放射線検査や侵襲的な処置を行うことは非現実的です。リキッドバイオプシーは、定期的な採血や尿検査による定期的ながんスクリーニングの可能性を解き放ちます。がんの早期発見のために、特異性の高い循環マーカーを同定することができます。

リキッドバイオプシーはまた、がん患者の治療後のモニタリングにも用いられます。がん細胞は治療後、画像検査の解像度や検出レベルを下回るレベルで体内に残存することがあり、この状態を微小残存病変と呼びます。この疾患はがん寛解の主な原因と考えられています。がんのスクリーニングや早期発見と同様に、リキッドバイオプシーの臨床応用は、現在の検査の感度と特異度によって制限されています。しかし、この感度の限界のために、リキッドバイオプシー技術は血液がんよりも固形がんの微小残存病変の検出に用いることができます。リキッドバイオプシーの助けを借りて、ヘルスケア専門家はがんの再発のケースをモニターすることができ、適切な診断の助けを借りて早期に治療することができます。

ゲフィチニブ、エルロチニブ、クリゾチニブ、セリチニブなどの特定のチロシンキナーゼ阻害剤に最初は感受性がある腫瘍は、しばしば変異を起こし、これらの薬剤に対して耐性を獲得します。リキッドバイオプシーは腫瘍の状態の変化を検出し、医師が患者の体内でどの薬剤に対しても耐性が生じないように治療戦略を修正するのに役立ちます。このように、リキッドバイオプシーはがんの早期発見を可能にし、医療従事者が治療の正確な方針を決定するのに役立ちます。さらに、治療や治療後の患者の状態をモニターするのにも役立ちます。このように、がん患者のモニタリングにおけるリキッドバイオプシーの利用に注目が集まっており、予測期間中にリキッドバイオプシー手技用採血管大きな需要を生み出すと思われます。

アジア太平洋のリキッドバイオプシー用採血管市場概要

アジア太平洋のリキッドバイオプシー用採血管市場は、中国、日本、インド、オーストラリア、韓国、その他アジア太平洋に区分されます。同地域のがん患者数の急増により、採血管需要が増加しています。さらに、ヘルスケアインフラを強化し、調査研究を支援する政府の取り組みが、予測期間中に市場成長の大きな機会を生み出すと期待されています。中国では、ヘルスケアインフラへの政府の多額の投資と充実した医療サービスの提供がリキッドバイオプシー用採血管市場に利益をもたらしています。がん症例数の増加も、リキッドバイオプシーなどの高度な診断ツールに対するニーズの高まりを示し、市場成長に寄与しています。2017年5月、Streckは中国の総合分子診断薬販売代理店であるGenomePrecision Technologyと細胞安定化、分子、尿検査、フローサイトメトリー製品の販売契約を締結しました。Cell-Free DNA BCTとCell-Free RNA BCT（いずれも有核血球を安定化させる）、Cell-Free DNA Urine Preserveはストレックの細胞安定化製品の一つです。このことは、中国の主要市場プレーヤーが、同国市場の成長機会をつかむため、製品アクセスの強化に注力していることを意味しています。さらに、Vazyme BiotechやCNWTCなどのバイオテクノロジー企業は、cfDNAチューブ、リキッドバイオプシーキット、創薬、分子研究などの製品を提供しています。

アジア太平洋のリキッドバイオプシー用採血管市場収益と2031年までの予測（金額）

アジア太平洋のリキッドバイオプシー用採血管市場セグメンテーション

アジア太平洋のリキッドバイオプシー用採血管市場は、製品、材料、用途、エンドユーザー、国に分類されます。

製品別では、アジア太平洋のリキッドバイオプシー用採血管市場は、ccfDNA/cfDNAチューブ、cfRNAチューブ、CTCチューブ、gDNAチューブ、細胞内RNAチューブ、その他に区分されます。ccfDNA/cfDNAチューブセグメントは、2023年にアジア太平洋のリキッドバイオプシー用採血管市場シェアで最大のシェアを占めました。

材料では、アジア太平洋のリキッドバイオプシー用採血管市場はプラスチックとガラスに区分されます。2023年のアジア太平洋のリキッドバイオプシー用採血管市場シェアでは、プラスチックセグメントが大きなシェアを占めています。

用途別では、アジア太平洋のリキッドバイオプシー用採血管市場は体外診断（IVD）と研究に二分されます。2023年のアジア太平洋のリキッドバイオプシー用採血管市場シェアでは、体外診断（IVD）分野が大きなシェアを占めています。

エンドユーザー別では、アジア太平洋のリキッドバイオプシー用採血管市場は遺伝子診断ラボ、研究開発センター、従来型診断センター、その他に区分されます。2023年のアジア太平洋のリキッドバイオプシー用採血管市場シェアでは、遺伝子診断ラボ部門が最大シェアを占めています。

国別に見ると、アジア太平洋のリキッドバイオプシー用採血管市場は、中国、日本、インド、オーストラリア、韓国、その他アジア太平洋に区分されます。2023年には中国セグメントがアジア太平洋のリキッドバイオプシー用採血管市場で最大のシェアを占めています。

Biocept Inc、Exact Sciences Corp、F. Hoffmann-La Roche Ltd、Greiner Bio-One International GmbH、MagBio Genomics, Inc、Norgen Biotek Corp、QIAGEN NV、Streck Inc、and Zymo Research Corporationは、アジア太平洋のリキッドバイオプシー用採血管市場で事業を展開している主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 2次調査
  • 1次調査
    • 仮説の策定
    • マクロ経済要因分析
    • ファンデーション数値の開発
    • データの三角測量
    • 国レベルのデータ

第4章 アジア太平洋のリキッドバイオプシー用採血管市場：主要市場力学

  • アジア太平洋のリキッドバイオプシー用採血管市場：主要市場力学
  • 市場促進要因
    • がんの有病率の増加
    • 他の診断検査技術に対するリキッドバイオプシーの優位性
  • 市場抑制要因
    • 熟練した専門家の不足
  • 市場機会
    • がんモニタリングにおけるリキッドバイオプシーの利用
  • 今後の動向
    • リキッドバイオプシーにおける技術の進歩
  • 促進要因と抑制要因の影響

第5章 リキッドバイオプシー用採血管市場：アジア太平洋分析

  • アジア太平洋のリキッドバイオプシー用採血管市場収益、2021年～2031年
  • アジア太平洋のリキッドバイオプシー用採血管市場予測分析

第6章 アジア太平洋のリキッドバイオプシー用採血管市場分析：製品別

  • ccfDNA/cfDNAチューブ
  • cfRNAチューブ
  • CTCチューブ
  • gDNAチューブ
  • 細胞内RNAチューブ
  • その他

第7章 アジア太平洋のリキッドバイオプシー用採血管市場分析：材料別

  • プラスチック
  • ガラス

第8章 アジア太平洋のリキッドバイオプシー用採血管市場分析：用途別

  • 体外診断薬（IVD）
  • 研究

第9章 アジア太平洋のリキッドバイオプシー用採血管市場分析：エンドユーザー別

  • 遺伝子診断ラボ
  • 研究開発センター
  • 従来の診断センター
  • その他

第10章 アジア太平洋のリキッドバイオプシー用採血管市場：国別分析

  • アジア太平洋のリキッドバイオプシー用採血管市場：主要国別（2023年、金額）
    • アジア太平洋
      • 中国
      • 日本
      • インド
      • オーストラリア
      • 韓国
      • その他のアジア太平洋

第11章 リキッドバイオプシー用採血管市場：業界情勢

  • リキッドバイオプシー用採血管市場の成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第12章 企業プロファイル

  • Biocept Inc
  • F. Hoffmann-La Roche Ltd
  • Norgen Biotek Corp
  • Exact Sciences Corp
  • QIAGEN NV
  • Greiner Bio-One International GmbH
  • Streck Inc
  • MagBio Genomics, Inc
  • Zymo Research Corporation

第13章 付録

図表

List Of Tables

  • Table 1. Asia Pacific Blood Collection Tubes for Liquid Biopsy Market Segmentation
  • Table 2. Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Table 3. Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Product
  • Table 4. Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Material
  • Table 5. Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Application
  • Table 6. Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by End User
  • Table 7. China: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Product
  • Table 8. China: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Material
  • Table 9. China: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Application
  • Table 10. China: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by End User
  • Table 11. Japan: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Product
  • Table 12. Japan: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Material
  • Table 13. Japan: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Application
  • Table 14. Japan: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by End User
  • Table 15. India: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Product
  • Table 16. India: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Material
  • Table 17. India: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Application
  • Table 18. India: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by End User
  • Table 19. Australia: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Product
  • Table 20. Australia: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Material
  • Table 21. Australia: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Application
  • Table 22. Australia: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by End User
  • Table 23. South Korea: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Product
  • Table 24. South Korea: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Material
  • Table 25. South Korea: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Application
  • Table 26. South Korea: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by End User
  • Table 27. Rest of APAC: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Product
  • Table 28. Rest of APAC: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Material
  • Table 29. Rest of APAC: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by Application
  • Table 30. Rest of APAC: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand) - by End User
  • Table 31. Recent Organic Growth Strategies in Blood Collection Tubes for Liquid Biopsy Market
  • Table 32. Recent Inorganic Growth Strategies in the Blood Collection Tubes for Liquid Biopsy Market

List Of Figures

  • Figure 1. Asia Pacific Blood Collection Tubes for Liquid Biopsy Market Segmentation, by Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. Asia Pacific Blood Collection Tubes for Liquid Biopsy Market Revenue (US$ Thousand), 2021-2031
  • Figure 4. Asia Pacific Blood Collection Tubes for Liquid Biopsy Market Share (%) - by Product (2023 and 2031)
  • Figure 5. ccfDNA/cfDNA Tubes: Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 6. cfRNA Tubes: Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 7. CTC Tubes: Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 8. gDNA Tubes: Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 9. Intracellular RNA Tubes: Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 10. Others: Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 11. Asia Pacific Blood Collection Tubes for Liquid Biopsy Market Share (%) - by Material (2023 and 2031)
  • Figure 12. Plastic: Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 13. Glass: Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 14. Asia Pacific Blood Collection Tubes for Liquid Biopsy Market Share (%) - by Application (2023 and 2031)
  • Figure 15. In-vitro Diagnostics (IVD): Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 16. Research: Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 17. Asia Pacific Blood Collection Tubes for Liquid Biopsy Market Share (%) - by End User (2023 and 2031)
  • Figure 18. Genetic Diagnostic Labs: Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 19. Research and Development Centres: Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 20. Conventional Diagnostic Centres: Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 21. Others: Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 22. Asia Pacific Blood Collection Tubes for Liquid Biopsy Market by Key Countries - Revenue (2023) US$ Million
  • Figure 23. Asia Pacific: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 24. China: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 25. Japan: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 26. India: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 27. Australia: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 28. South Korea: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 29. Rest of APAC: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 30. Growth Strategies in Blood Collection Tubes for Liquid Biopsy Market
目次
Product Code: TIPRE00027972

The Asia Pacific blood collection tubes for liquid biopsy market was valued at US$ 28,746.23 million in 2023 and is expected to reach US$ 1,16,169.56 million by 2031; it is estimated to register a CAGR of 19.1% from 2023 to 2031.

Use of Liquid Biopsy in Cancer Monitoring Boosts Asia Pacific Blood Collection Tubes for Liquid Biopsy Market

There is a growing focus on employing liquid biopsy procedures for monitoring cancer growth, detecting genetic mutations, identifying signs of relapse, and predicting sensitivity to immunotherapy. The early detection of cancer results in better outcomes; for example, patients with early detection show higher remission and survival rates than those with late-stage or malignant cancer. However, it is impractical to perform serial radiological testing or invasive procedures for cancer surveillance to detect cancer in the early stages when symptoms are not evident. Liquid biopsy unlocks the possibility of periodic cancer screening through routine blood draws or urinalyses. It can identify highly specific and circulating markers for early cancer detection.

Liquid biopsy procedures are also employed for post-treatment monitoring of cancer patients. Cancer cells may persist in the body after treatment at levels below the resolution and detection levels of imaging studies; the condition is termed a minimal residual disease. This disease is considered a principal cause of cancer remission. Similar to that in cancer screening and early detection, the clinical application of liquid biopsy is limited by the sensitivity and specificity of current tests. However, due to this sensitivity limitation, liquid biopsy techniques can be used for detecting minimal residual disease for solid tumors than blood cancers. With the help of liquid biopsy, the healthcare professional can monitor the case of reoccurrence of cancer, which can then be treated early with the help of proper diagnosis.

Tumors that are initially susceptible to specific tyrosine kinase inhibitors, including gefitinib, erlotinib, crizotinib, and ceritinib, often mutate and develop resistance to these drugs. Liquid biopsy detects the changes in the tumor status and helps doctors modify the treatment strategies to avoid the development of resistance to any medication in the patient's body. Thus, liquid biopsy allows the early detection of cancer and helps healthcare professionals determine the exact course of action for treatment. In addition, it helps monitor treatments and the condition of the patient after the treatment. Thus, there is an increase in focus on the use of liquid biopsy in the monitoring of cancer patients, which is likely to create a significant demand for blood collection tubes for liquid biopsy procedures during the forecast period.

Asia Pacific Blood Collection Tubes for Liquid Biopsy Market Overview

The Asia Pacific blood collection tube for liquid biopsy market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The demand for blood collection tubes is increasing due to an upsurge in the number of cancer patients in the region. Moreover, government initiatives to enhance healthcare infrastructure and support research studies are expected to create significant opportunities for market growth during the forecast period. In China, significant government investments in healthcare infrastructure and emphasis on providing enhanced medical services benefit the blood collection tubes for liquid biopsy market. The increasing number of cancer cases is also contributing to the market growth, as it indicates the elevated need for sophisticated diagnostic tools such as liquid biopsies. In May 2017, Streck signed a distribution agreement with GenomePrecision Technology, an integrated molecular diagnostics distributor in China, for its cell stabilization, molecular, urinalysis, and flow cytometry products. Cell-Free DNA BCT and Cell-Free RNA BCT (both stabilize nucleated blood cells), and Cell-Free DNA Urine Preserve are among Streck's cell stabilization products. This signifies that key market players in China focus on enhancing their product access to grab growth opportunities in the market in this country. Further, biotechnology companies such as Vazyme Biotech and CNWTC offer products for cfDNA tubes, liquid biopsy kits, drug discovery, molecular research, and more.

Asia Pacific Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecast to 2031 (US$ Million)

Asia Pacific Blood Collection Tubes for Liquid Biopsy Market Segmentation

The Asia Pacific blood collection tubes for liquid biopsy market is categorized into product, material, application, end user, country.

By product, the Asia Pacific blood collection tubes for liquid biopsy market is segmented into ccfDNA/cfDNA Tubes, cfRNA Tubes, CTC Tubes, gDNA Tubes, intracellular RNA Tubes, and others. The ccfDNA/cfDNA Tubes segment held the largest share of the Asia Pacific blood collection tubes for liquid biopsy market share in 2023.

In terms of material, the Asia Pacific blood collection tubes for liquid biopsy market is segmented into plastic and glass. The plastic segment held a larger share of the Asia Pacific blood collection tubes for liquid biopsy market share in 2023.

By application, the Asia Pacific blood collection tubes for liquid biopsy market is bifurcated into in-vitro diagnostics (IVD) and research. The in-vitro diagnostics (IVD) segment held a larger share of the Asia Pacific blood collection tubes for liquid biopsy market share in 2023.

In terms of end user, the Asia Pacific blood collection tubes for liquid biopsy market is segmented into genetic diagnostic labs, research and development centers, conventional diagnostic centers, and others. The genetic diagnostic labs segment held the largest share of the Asia Pacific blood collection tubes for liquid biopsy market share in 2023.

Based on country, the Asia Pacific blood collection tubes for liquid biopsy market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China segment held the largest share of Asia Pacific blood collection tubes for liquid biopsy market in 2023.

Biocept Inc; Exact Sciences Corp; F. Hoffmann-La Roche Ltd; Greiner Bio-One International GmbH; MagBio Genomics, Inc; Norgen Biotek Corp; QIAGEN NV; Streck Inc; and Zymo Research Corporation are some of the leading companies operating in the Asia Pacific blood collection tubes for liquid biopsy market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Key Market Dynamics

  • 4.1 Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Key Market Dynamics
  • 4.2 Market Drivers:
    • 4.2.1 Increase in Prevalence of Cancer
    • 4.2.2 Advantages of Liquid Biopsy Over Other Diagnostic Testing Techniques
  • 4.3 Market Restraints
    • 4.3.1 Lack of Skilled Professionals
  • 4.4 Market Opportunities
    • 4.4.1 Use of Liquid Biopsy in Cancer Monitoring
  • 4.5 Future Trends
    • 4.5.1 Technological Advancements in Liquid Biopsy
  • 4.6 Impact of Drivers and Restraints:

5. Blood Collection Tubes for Liquid Biopsy Market - Asia Pacific Analysis

  • 5.1 Asia Pacific Blood Collection Tubes for Liquid Biopsy Market Revenue (US$ Thousand), 2021-2031
  • 5.2 Asia Pacific Blood Collection Tubes for Liquid Biopsy Market Forecast Analysis

6. Asia Pacific Blood Collection Tubes for Liquid Biopsy Market Analysis - by Product

  • 6.1 ccfDNA/cfDNA Tubes
    • 6.1.1 Overview
    • 6.1.2 ccfDNA/cfDNA Tubes: Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 6.2 cfRNA Tubes
    • 6.2.1 Overview
    • 6.2.2 cfRNA Tubes: Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 6.3 CTC Tubes
    • 6.3.1 Overview
    • 6.3.2 CTC Tubes: Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 6.4 gDNA Tubes
    • 6.4.1 Overview
    • 6.4.2 gDNA Tubes: Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 6.5 Intracellular RNA Tubes
    • 6.5.1 Overview
    • 6.5.2 Intracellular RNA Tubes: Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 6.6 Others
    • 6.6.1 Overview
    • 6.6.2 Others: Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)

7. Asia Pacific Blood Collection Tubes for Liquid Biopsy Market Analysis - by Material

  • 7.1 Plastic
    • 7.1.1 Overview
    • 7.1.2 Plastic: Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 7.2 Glass
    • 7.2.1 Overview
    • 7.2.2 Glass: Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)

8. Asia Pacific Blood Collection Tubes for Liquid Biopsy Market Analysis - by Application

  • 8.1 In-vitro Diagnostics (IVD)
    • 8.1.1 Overview
    • 8.1.2 In-vitro Diagnostics (IVD): Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 8.2 Research
    • 8.2.1 Overview
    • 8.2.2 Research: Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)

9. Asia Pacific Blood Collection Tubes for Liquid Biopsy Market Analysis - by End User

  • 9.1 Genetic Diagnostic Labs
    • 9.1.1 Overview
    • 9.1.2 Genetic Diagnostic Labs: Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 9.2 Research and Development Centres
    • 9.2.1 Overview
    • 9.2.2 Research and Development Centres: Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 9.3 Conventional Diagnostic Centres
    • 9.3.1 Overview
    • 9.3.2 Conventional Diagnostic Centres: Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 9.4 Others
    • 9.4.1 Overview
    • 9.4.2 Others: Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)

10. Asia Pacific Blood Collection Tubes for Liquid Biopsy Market - Country Analysis

  • 10.1 Asia Pacific Blood Collection Tubes foe Liquid Biopsy Market , by Key Countries (2023 US$ Million
    • 10.1.1 Asia Pacific: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.1 China: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 10.1.1.1.1 China: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
        • 10.1.1.1.2 China: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
        • 10.1.1.1.3 China: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
        • 10.1.1.1.4 China: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
      • 10.1.1.2 Japan: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 10.1.1.2.1 Japan: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
        • 10.1.1.2.2 Japan: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
        • 10.1.1.2.3 Japan: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
        • 10.1.1.2.4 Japan: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
      • 10.1.1.3 India: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 10.1.1.3.1 India: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
        • 10.1.1.3.2 India: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
        • 10.1.1.3.3 India: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
        • 10.1.1.3.4 India: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
      • 10.1.1.4 Australia: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 10.1.1.4.1 Australia: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
        • 10.1.1.4.2 Australia: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
        • 10.1.1.4.3 Australia: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
        • 10.1.1.4.4 Australia: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
      • 10.1.1.5 South Korea: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 10.1.1.5.1 South Korea: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
        • 10.1.1.5.2 South Korea: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
        • 10.1.1.5.3 South Korea: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
        • 10.1.1.5.4 South Korea: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
      • 10.1.1.6 Rest of APAC: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 10.1.1.6.1 Rest of APAC: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
        • 10.1.1.6.2 Rest of APAC: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
        • 10.1.1.6.3 Rest of APAC: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
        • 10.1.1.6.4 Rest of APAC: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User

11. Blood Collection Tubes for Liquid Biopsy Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Blood Collection Tubes for Liquid Biopsy Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Biocept Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 F. Hoffmann-La Roche Ltd
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Norgen Biotek Corp
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Exact Sciences Corp
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 QIAGEN NV
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Greiner Bio-One International GmbH
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Streck Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 MagBio Genomics, Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Zymo Research Corporation
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners